The Burden and Etiology of Diarrheal Illness in Developing Countries

Pediatric Clinics of North America

Volumn 64, Issue 4, 2017, Pages 799-814

  Kotloff, Karen L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Burden; Cryptosporidium; Developing countries; Diarrhea; ETEC; Gastroenteritis; Rotavirus; Shigella

Indexed keywords

ANTIBIOTIC AGENT; ROTAVIRUS VACCINE; ZINC;

AGE; CHILD DEATH; CLINICAL EVALUATION; CLINICAL OUTCOME; CRYPTOSPORIDIUM; DEHYDRATION; DEVELOPING COUNTRY; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG USE; ENTEROPATHOGENIC ESCHERICHIA COLI; GIARDIA; HIGH RISK POPULATION; HUMAN; INFECTION PREVENTION; MALNUTRITION; MORTALITY RATE; NONHUMAN; REFEEDING; REHYDRATION; REVIEW; RISK FACTOR; ROTAVIRUS; SHIGELLA; SYMPTOM; VACCINATION; VIRUS INFECTION; CHILD; COST OF ILLNESS; INFANT; PRESCHOOL CHILD;

CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; DEVELOPING COUNTRIES; DIARRHEA; HUMANS; INFANT;

EID: 85025451938     PISSN: 00313955     EISSN: 15578240     Source Type: Journal    
DOI: 10.1016/j.pcl.2017.03.006     Document Type: Review

References (37)

1. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1545–1602.
2. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 388 (2016), 1459–1544.
3. Kotloff, K.L., Nataro, J.P., Blackwelder, W.C., et al. Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case-control study. Lancet 382 (2013), 209–222.
4. Todd, S., Page, N.A., Duncan Steele, A., et al. Rotavirus strain types circulating in Africa: review of studies published during 1997-2006. J Infect Dis 202:Suppl (2010), S34–S42.
5. Miles, M.G., Lewis, K.D., Kang, G., et al. A systematic review of rotavirus strain diversity in India, Bangladesh, and Pakistan. Vaccine 30:Suppl 1 (2012), A131–A139.
6. Warny, M., Pepin, J., Fang, A., et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366 (2005), 1079–1084.
7. Sow, S.O., Muhsen, K., Nasrin, D., et al. The burden of cryptosporidium diarrheal disease among children < 24 months of age in moderate/high mortality regions of sub-saharan Africa and south Asia, utilizing data from the global enteric multicenter study (GEMS). PLoS Negl Trop Dis, 10, 2016, e0004729.
8. Kotloff, K.L., Blackwelder, W.C., Nasrin, D., et al. The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: epidemiologic and clinical methods of the case/control study. Clin Infect Dis 55:Suppl 4 (2012), S232–S245.
9. MAL-ED Network Investigators. The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 years of age in resource-poor environments. Clin Infect Dis 59:Suppl 4 (2014), S193–S206.
10. Platts-Mills, J.A., Babji, S., Bodhidatta, L., et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Health 3 (2015), e564–575.
11. Liu, J., Platts-Mills, J.A., Juma, J., et al. Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: a reanalysis of the GEMS case-control study. Lancet 388 (2016), 1291–1301.
12. Molbak, K., Hojlyng, N., Gottschau, A., et al. Cryptosporidiosis in infancy and childhood mortality in Guinea Bissau, west Africa. BMJ 307 (1993), 417–420.
13. Qamar, F.N., Nisar, M.I., Quadri, F., et al. Aeromonas-associated diarrhea in children under 5 years: the GEMS experience. Am J Trop Med Hyg 95 (2016), 774–780.
14. Soltan Dallal, M.M., Moezardalan, K., Aeromonas spp associated with children's diarrhoea in Tehran: a case-control study. Ann Trop Paediatr 24 (2004), 45–51.
15. Feasey, N.A., Hadfield, J., Keddy, K.H., et al. Distinct Salmonella enteritidis lineages associated with enterocolitis in high-income settings and invasive disease in low-income settings. Nat Genet 48 (2016), 1211–1217.
16. Qadri, F., Das, S.K., Faruque, A.S., et al. Prevalence of toxin types and colonization factors in enterotoxigenic Escherichia coli isolated during a 2-year period from diarrheal patients in Bangladesh. J Clin Microbiol 38 (2000), 27–31.
17. Okwori, A.E., Martinez, P.O., Fredriksson-Ahomaa, M., et al. Pathogenic Yersinia enterocolitica 2/O:9 and Yersinia pseudotuberculosis 1/O:1 strains isolated from human and non-human sources in the Plateau State of Nigeria. Food Microbiol 26 (2009), 872–875.
18. Hollm-Delgado, M.G., Gilman, R.H., Bern, C., et al. Lack of an adverse effect of Giardia intestinalis infection on the health of Peruvian children. Am J Epidemiol 168:6 (2008), 647–655.
19. Tucker, A.W., Haddix, A.C., Bresee, J.S., et al. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 279 (1998), 1371–1376.
20. Lopman, B.A., Steele, D., Kirkwood, C.D., et al. The vast and varied global burden of norovirus: prospects for prevention and control. PLoS Med, 13, 2016, e1001999.
21. Rouhani, S., Penataro Yori, P., Paredes Olortegui, M., et al. Norovirus infection and acquired immunity in 8 countries: results from the MAL-ED study. Clin Infect Dis 62 (2016), 1210–1217.
22. Corvelo, T.C.O., Aguiar, D.C.F., Sagica, F.E.S., The expression of ABH and Lewis antigens in Brazilian semi-isolated black communities. Genet Mol Biol 25 (2002), 259–263.
23. Nordgren, J., Nitiema, L.W., Ouermi, D., et al. Host genetic factors affect susceptibility to norovirus infections in Burkina Faso. PLoS One, 8, 2013, e69557.
24. Amour, C., Gratz, J., Mduma, E., et al. Epidemiology and Impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin Infect Dis 63 (2016), 1171–1179.
25. Crump, J.A., Heyderman, R.S., A perspective on invasive salmonella disease in Africa. Clin Infect Dis 61:Suppl 4 (2015), S235–S240.
26. Steiner, M.J., DeWalt, D.A., Byerley, J.S., Is this child dehydrated?. JAMA 291 (2004), 2746–2754.
27. Gaston, J.S., Inman, R.D., Ryan, E.T., et al. Vaccination of children in low-resource countries against Shigella is unlikely to present an undue risk of reactive arthritis. Vaccine 27 (2009), 5432–5434.
28. Islam, Z., Gilbert, M., Mohammad, Q.D., et al. Guillain-Barre syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies. PLoS One, 7, 2012, e43976.
29. World Health Organization. Handbook: IMCI integrated management of childhood illness. 2005. http://www.who.int/maternal_child_adolescent/documents/9241546441/en/. Accessed March 22, 2012.
30. World Health Organization. Pocket book of hospital care for children: guideline for the management of common illnesses with limited resources. 2005. Available at: http://whqlibdoc.who.int/publications/2005/9241546700.pdf. Accessed December 11, 2013.
31. Patel, M.M., Glass, R., Desai, R., et al. Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?. Lancet Infect Dis 12 (2012), 561–570.
32. Dennehy, P.H., Treatment and prevention of rotavirus infection in children. Curr Infect Dis Rep 15 (2013), 242–250.
33. do Carmo, G.M., Yen, C., Cortes, J., et al. Decline in diarrhea mortality and admissions after routine childhood rotavirus immunization in Brazil: a time-series analysis. PLoS Med, 8, 2011, e1001024.
34. Richardson, V., Hernandez-Pichardo, J., Quintanar-Solares, M., et al. Effect of rotavirus vaccination on death from childhood diarrhea in Mexico. N Engl J Med 362 (2010), 299–305.
35. Zaman, K., Dang, D.A., Victor, J.C., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 376 (2010), 615–623.
36. Armah, G.E., Sow, S.O., Breiman, R.F., et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 376 (2010), 606–614.
37. Colgate, E.R., Haque, R., Dickson, D.M., et al. Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial. Clin Infect Dis 63 (2016), 634–641.